The Science of Telomeres and Aging
Telomeres — the protective caps at the ends of chromosomes — have become central to aging research over the past two decades. Each time a cell divides, telomeres shorten slightly. When telomeres become critically short, cells enter senescence or undergo apoptosis. This progressive shortening is considered one of the hallmarks of biological aging, as described in the landmark 2013 Cell paper by López-Otín and colleagues.
The enzyme telomerase — a ribonucleoprotein complex consisting of a reverse transcriptase (TERT) and an RNA template (TERC) — can extend telomere length. However, telomerase activity is largely suppressed in most adult somatic cells, contributing to age-related telomere attrition.
What Is Epitalon?
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). It was developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology, based on research into pineal gland peptide extracts (epithalamin).
The hypothesis behind epitalon is that it may act as a telomerase activator — specifically, that it stimulates telomerase expression in somatic cells that normally have suppressed telomerase activity. If confirmed, this mechanism would make epitalon a valuable research tool for studying telomere biology and cellular senescence.
Published Research
Several published studies have investigated epitalon effects on telomerase activity and cell proliferation. In vitro studies on human fetal lung fibroblasts reported that epitalon treatment was associated with increased telomerase activity and extended replicative capacity beyond the Hayflick limit. Separate animal studies conducted over 25 years by Khavinson research group reported associations between epitalon treatment and extended lifespan in various model organisms.
It is important to note that much of the primary research on epitalon comes from a single research group, and large-scale independent replications in Western laboratories are limited. This makes it an active and open area of investigation rather than established scientific consensus.
Current Research Directions
Modern researchers are investigating epitalon in several contexts: cellular senescence models studying whether AEDG tetrapeptide can delay or reverse senescent phenotypes, pineal gland function research examining melatonin synthesis regulation, circadian rhythm studies exploring peptide bioregulation effects on circadian clock genes, and comparative studies alongside other putative telomerase activators such as TA-65 and cycloastragenol.
Research Quality Considerations
Epitalon is a small tetrapeptide (molecular weight ~390 Da), making it relatively straightforward to synthesize at high purity. However, researchers should still verify peptide identity via mass spectrometry and demand HPLC purity documentation ≥98%. Given the small molecular size, even minor impurities can represent a significant molar fraction of contaminants.
CertaPeptides offers Epitalon 50mg research vials with HPLC-verified purity and full COA documentation.
For research and educational purposes only. Epitalon is sold as a research chemical and is not intended for human use.